xantinol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| N-methylated xanthine derivatives | 4368 | 437-74-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A vasodilator used in peripheral vascular disorders and insufficiency. It may cause gastric discomfort and hypotension.
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 0.90 | g | O |
| 0.90 | g | P |
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | C04AD02 | CARDIOVASCULAR SYSTEM PERIPHERAL VASODILATORS PERIPHERAL VASODILATORS Purine derivatives |
| CHEBI has role | CHEBI:25212 | metabolites |
| CHEBI has role | CHEBI:35620 | vasodilator agents |
| CHEBI has role | CHEBI:35679 | antilipemic drugs |
| CHEBI has role | CHEBI:50247 | antidotes |
| CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
| CHEBI has role | CHEBI:76924 | plant metabolites |
| CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
| CHEBI has role | CHEBI:84087 | human urinary metabolites |
| CHEBI has role | CHEBI:84264 | nicotinamide deaminase inhibitors |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D014665 | Vasodilator Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 13.25 | acidic |
| pKa2 | 7.86 | Basic |
| pKa3 | 1.66 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D06334 | KEGG_DRUG |
| N0000167330 | NUI |
| 2530-97-4 | SECONDARY_CAS_RN |
| 4017661 | VANDF |
| 4019440 | VANDF |
| C0301387 | UMLSCUI |
| CHEBI:94314 | CHEBI |
| CHEBI:15940 | CHEBI |
| NIO | PDB_CHEM_ID |
| 9913 | PUBCHEM_CID |
| DB09092 | DRUGBANK_ID |
| CHEMBL1624126 | ChEMBL_ID |
| CHEMBL1560089 | ChEMBL_ID |
| 11358 | RXNORM |
| 2275 | MMSL |
| 5169 | MMSL |
| 7161 | MMSL |
| d00314 | MMSL |
| 001052 | NDDF |
| 003508 | NDDF |
| 10500003 | SNOMEDCT_US |
| 273943001 | SNOMEDCT_US |
| 63639004 | SNOMEDCT_US |
| 708562005 | SNOMEDCT_US |
| D014971 | MESH_DESCRIPTOR_UI |
| C0027996 | UMLSCUI |
| DB00627 | DRUGBANK_ID |
| 1492 | INN_ID |
| 938 | PUBCHEM_CID |
| TN1B5910V2 | UNII |
Pharmaceutical products:
None